Endogenous Gastrin Collaborates With Mutant KRAS in Pancreatic Carcinogenesis-Reference-Cited by-同舟云学术

Endogenous Gastrin Collaborates With Mutant KRAS in Pancreatic Carcinogenesis

Published:2019-07-02 Issue:7 Volume:48 Page:894-903
ISSN:1536-4828
Container-title:Pancreas
language:en
Short-container-title:Pancreas

Author:

Nadella Sandeep,Burks Julian,Huber Matthew,Wang Juan,Cao Hong,Kallakury Bhaskar,Tucker Robin D.,Boca Simina M.,Jermusyck Ashley,Collins Irene,Vietsch Eveline E.,Pierobon Mariaelena,Hodge K. Alex,Cui Waxing,Amundadottir Laufey T.,Petricoin Emanuel,Shivapurkar Narayan,Smith Jill P.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Endocrinology,Hepatology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference83 articles.

1. The gastrins: their production and biological activities;Annu Rev Physiol,2001

2. Gastrin receptor pharmacology;Curr Gastroenterol Rep,2012

3. Cholecystokinin and gastrin receptors;Physiol Rev,2006

4. Gastrin and upper GI cancers;Curr Opin Pharmacol,2016

5. Gastrin and cancer: a review;Cancer Lett,2006

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies;European Journal of Clinical Pharmacology;2023-04-20

2. Target-Specific Nanoparticle Polyplex Down-Regulates Mutant Kras to Prevent Pancreatic Carcinogenesis and Halt Tumor Progression;International Journal of Molecular Sciences;2023-01-01

3. Laser Capture Microdissection: A Gear for Pancreatic Cancer Research;International Journal of Molecular Sciences;2022-11-23

4. Does Chronic Use of High Dose Proton Pump Inhibitors Increase Risk for Pancreatic Cancer?;Pancreas;2022-10

5. Cholecystokinin-B Receptor-Targeted Nanoparticle for Imaging and Detection of Precancerous Lesions in the Pancreas;Biomolecules;2021-11-25